MannKind Corp
MNKD
#6425
Rank
A$1.11 B
Marketcap
A$3.63
Share price
-1.53%
Change (1 day)
-51.85%
Change (1 year)

MannKind Corp (MNKD) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.16 Billion

According to MannKind Corp's latest financial reports the company's total debt is A$0.16 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

MannKind Corp - Total debt on balance sheet (from 2006 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$76.68 M-80.84%
2023-12-31A$0.40 B-2.34%
2022-12-31A$0.40 B5.25%
2021-12-31A$0.38 B142.51%
2020-12-31A$0.16 B-7.43%
2019-12-31A$0.17 B19.2%
2018-12-31A$0.14 B-27.58%
2017-12-31A$0.20 B-2.49%
2016-12-31A$0.20 B-29.9%
2015-12-31A$0.29 B6.94%
2014-12-31A$0.27 B-2.05%
2013-12-31A$0.28 B-12.09%
2012-12-31A$0.31 B-32.92%
2011-12-31A$0.47 B8.69%
2010-12-31A$0.43 B41.57%
2009-12-31A$0.30 B53.35%
2008-12-31A$0.20 B57.73%
2007-12-31A$0.12 B-9.43%
2006-12-31A$0.14 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
A$90.25 B 53,240.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$29.06 B 17,077.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
A$59.97 B 35,345.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$69.62 B 41,046.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$3.02 B 1,686.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$0.12 B-28.49%๐Ÿ‡บ๐Ÿ‡ธ USA